TRANSIFAST
Food supplement declared in France, declaration No 2019-2-162, decision dated 5 February 2019
TRANSIFAST (3C PHARMA) is a food supplement declared in France. Status: déclaré en France, commercialisation possible : l'administration ne s'est pas opposée à la déclaration (ce n'est ni une autorisation ni une évaluation de sécurité). 1 point in its composition requires a check (prohibited substance, dose or novel food). 2 rules of use apply to its ingredients (limits and warnings).
- Brand
- 3C PHARMA
- Food business operator placing the product on the market
- LES TROIS CHENES
- Status
- Déclaré en France, commercialisation possible : l'administration ne s'est pas opposée à la déclaration (ce n'est ni une autorisation ni une évaluation de sécurité)
- Form
- Flacon
- Daily dose
- 1
- Directions for use
- Prendre 1 cuillères à soupe (10ml) par jour
- Not recommended for (according to the manufacturer)
- Femmes allaitantes, Antécédent de cancer du sein, Enfants (moins de 12 ans), Femmes enceintes, Utilisation prolongée
- Objectives stated by the manufacturer (these are not authorised claims)
- Transit
- Flavourings
- fraise
Declaration 293530, procedure Article 15. Compl'Alim, food supplement declarations (France), retrieved 23 October 2026.
Regulatory points
- À vérifier
Contains a preparation of senna (Cassia senna) (feuille). Preparations from this plant part containing hydroxyanthracene derivatives are under Union scrutiny (Annex III, Part C): a draft regulation sent to the Council on 15 July 2026 would prohibit them, with 12 months to sell through products already on the market. Their content is not declared.
Source: Regulation (EC) No 1925/2006, latest consolidated version, annexe III, partie C (règlement (UE) 2021/468) ; projet de la Commission D099926/3.
- Conditions légales
Linum usitatissimum L.: L'étiquetage doit comporter un avertissement déconseillant l'usage chez les femmes ayant des antécédents personnels ou familiaux de cancer du sein.
Source: French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, arrêté du 24 juin 2014, annexe I.
- Conditions légales
Senna alexandrina Mill.: L'étiquetage doit comporter un avertissement déconseillant l'emploi aux enfants de moins de 12 ans, aux femmes enceintes et allaitantes et une mention déconseillant l'usage prolongé.
Source: French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, arrêté du 24 juin 2014, annexe I.
Declared composition
Plants
| Plant | Part | Preparation | Per day |
|---|---|---|---|
| Prunus domestica L. | Fruit | Pression à froid | 125 mg |
| Ficus carica L. | Fruit | Pression à froid | 50 mg |
| Senna alexandrina Mill. | Feuille | Extrait fluide aqueux | 3 g |
| Linum usitatissimum L. | Graine | Extrait fluide aqueux | 1.5 g |
| Cynara scolymus L. | Feuille | Extrait fluide aqueux | 0.75 g |
Other active ingredients
| Name | Per day |
|---|---|
| Fructo-oligosaccharides | not declared |
Additives
E202, E211, E330, E955
Other ingredients
eau
List from the declaration, administrative decision dated (Compl'Alim, food supplement declarations (France)).
List recorded in 2019. Photograph the packaging to check whether it has changed. Photograph the packaging
This information reproduces the manufacturer's declaration to the administration (DGAL). It does not say whether the product is effective and does not replace advice from a doctor or pharmacist, particularly during pregnancy or when taking medication.
Other declarations with the same name
In France, every company that markets a supplement declares it, so one product can have several declarations (new formula, another distributor, an older declaration withdrawn). Each line compares the declared composition with this page.
- TRANSIFAST 3 CHENES, declared in 2019 : different composition: 2 ingredient(s) added, 4 missing
Brand : 3C PHARMA